In the last trading session, 2.47 million shares of the Syros Pharmaceuticals Inc. (NASDAQ:SYRS) were traded, and its beta was 1.58. Most recently the company’s
Syros Pharmaceuticals Inc. (NASDAQ:SYRS)’s traded shares stood at 1.28 million during the latest session, with the company’s beta value hitting 1.58. At the last check
Syros Pharmaceuticals Inc. (NASDAQ:SYRS) has a beta value of 1.62 and has seen 0.11 million shares traded in the last trading session. The company, currently
In last trading session, Syros Pharmaceuticals Inc. (NASDAQ:SYRS) saw 0.33 million shares changing hands with its beta currently measuring 1.66. Company’s recent per share price
Syros Pharmaceuticals Inc. (NASDAQ:SYRS) has a beta value of 1.65 and has seen 4.8 million shares traded in the last trading session. The company, currently
Syros Pharmaceuticals Inc. (NASDAQ:SYRS) has a beta value of 1.65 and has seen 3.51 million shares traded in the recent trading session. The company, currently
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
